Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 May 12:5:28.
doi: 10.1186/1746-1596-5-28.

Evaluation of neuroendocrine markers in renal cell carcinoma

Hanna Ronkainen  1 , Ylermi Soini, Markku H Vaarala, Saila Kauppila, Pasi Hirvikoski
Affiliations

Evaluation of neuroendocrine markers in renal cell carcinoma

Hanna Ronkainen et al. Diagn Pathol. .

Abstract

Background: The purpose of the study was to examine serotonin, CD56, neurone-specific enolase (NSE), chromogranin A and synaptophysin by immunohistochemistry in renal cell carcinomas (RCCs) with special emphasis on patient outcome.

Methods: We studied 152 patients with primary RCCs who underwent surgery for the removal of kidney tumours between 1990 and 1999. The mean follow-up was 90 months. The expression of neuroendocrine (NE) markers was determined by immunohistochemical staining using commercially available monoclonal antibodies. Results were correlated with patient age, clinical stage, Fuhrman grade and patient outcome.

Results: Eight percent of tumours were positive for serotonin, 18% for CD56 and 48% for NSE. Chromogranin A immunostaining was negative and only 1% of the tumours were synaptophysin immunopositive. The NSE immunopositivity was more common in clear cell RCCs than in other subtypes (p = 0.01). The other NE markers did not show any association with the histological subtype. Tumours with an immunopositivity for serotonin had a longer RCC-specific survival and tumours with an immunopositivity for CD56 and NSE had a shorter RCC-specific survival but the difference was not significant. There was no relationship between stage or Fuhrman grade and immunoreactivity for serotonin, CD56 and NSE.

Conclusions: Serotonin, CD56 and NSE but not synaptophysin and chromogranin A are expressed in RCCs. However, the prognostic potential of these markers remains obscure.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cytoplasmic serotonin as a prognostic factor in RCC-specific survival. Kaplan-Meier curve of 145 patients (p = 0.3).
See this image and copyright information in PMC

References

    1. Nesland JM, Holm R, Johannessen JV, Gould VE. Neuroendocrine differentiation in breast lesions. Pathol Res Pract. 1988;183:214–221. - PubMed
    1. Sun Y, Niu J, Huang J. Neuroendocrine differentiation in prostate cancer. Am J Transl Res. 2009;1:148–162. - PMC - PubMed
    1. IARC. Tumours of the Urinary System and Male Genital Organs. IARC Press, Lyon; 2004.
    1. Viallet J, Ihde DC. Small cell carcinoma of the lung: clinical and biologic aspects. Crit Rev Oncol Hematol. 1991;11:109–135. doi: 10.1016/1040-8428(91)90002-T. - DOI - PubMed
    1. Dahabreh J, Stathopoulos GP, Koutantos J, Rigatos S. Lung carcinoid tumor biology: treatment and survival. Oncol Rep. 2009;21:757–760. - PubMed

Publication types

MeSH terms